Benepass Secures $40M to Tackle Soaring Employee Healthcare Costs

NEW YORK, NY – January 21, 2026 – As employers brace for another year of staggering healthcare cost increases, benefits platform Benepass has secured $40 million in Series B funding to arm companies with more precise tools for cost control and employee choice. The round, led by fintech investor Centana Growth Partners, signals a significant move to address the mounting financial pressures on corporate benefit programs.

The funding arrives at a critical juncture. Employers are facing projected healthcare cost hikes of up to 10 percent this year, a trend fueled by increased medical service utilization, the prevalence of chronic conditions, and the surging expense of specialty drugs. This relentless climb in costs has created a difficult balancing act for companies trying to provide valuable benefits without overwhelming their budgets or shifting an untenable financial burden onto their employees.

A Perfect Storm of Healthcare Expenses

The challenge facing employers is not just a single-issue problem but a convergence of factors creating a perfect storm of financial strain. Industry analyses from firms like Mercer and Willis Towers Watson corroborate the severity of the situation, with some reports projecting the highest cost increases in over a decade. A major driver of this surge is the explosive growth and high price tag of specialty medications, particularly GLP-1 agonists like Ozempic and Wegovy, used for diabetes and weight management. The annual cost for these drugs can exceed $15,000 per patient, creating a significant new expense category for corporate health plans.

Historically, a common strategy for employers was to pass on rising costs to employees through higher premiums and deductibles. However, with household budgets already strained by inflation, this approach is losing its effectiveness and can negatively impact employee morale and financial wellness. More than a quarter of employers have recently resorted to this cost-shifting, but many are now seeking more sustainable and strategic alternatives. This industry-wide dilemma has created a fertile ground for innovative solutions that offer control without compromising the quality or accessibility of care.

"Benepass has demonstrated strong momentum across customer adoption, and platform usage," said Matthew Alfieri, Partner at Centana Growth Partners. "What stood out in diligence was the consistency of customer praise across flexibility, its user experience, and a highly collaborative support model, which reinforced our conviction that Benepass is well-positioned helping employers manage benefit dollars with greater precision and flexibility."

Targeted Solutions for Complex Problems

With the new $40 million infusion, Benepass plans to aggressively expand its platform's capabilities, focusing on serving larger, more complex organizations. A key part of this strategy involves enhancing its pre-tax benefit offerings, which create a financial win-win for both companies and their staff.

The company will make a significant investment in its Health Savings Account (HSA) product, aiming to boost employee participation through integrated enrollment and a low $125 minimum investment threshold. By encouraging employees to use pre-tax accounts like HSAs and Flexible Spending Accounts (FSAs), Benepass helps lower their taxable income and out-of-pocket medical costs. In turn, employers benefit from reduced payroll tax liability, making these programs a rare bright spot in the otherwise grim landscape of healthcare finance.

More pointedly, Benepass is rolling out Specialty Health Reimbursement Accounts (HRAs) as a direct answer to the GLP-1 cost crisis. These accounts provide employers with a highly controlled mechanism to fund specific treatments. Companies can define which medications are eligible, restrict purchases to specific merchants, and even require participation in complementary wellness interventions like nutrition counseling or fitness programs. This allows employers to support employees seeking weight management treatments without adding the full, uncapped cost to their primary insurance plan, which could drive up premiums for the entire workforce.

Redefining the Modern Benefit Experience

While cost control is a primary driver, Benepass's strategy is equally focused on improving the employee experience. In a world of increasingly complex and siloed benefit offerings, many employees struggle to understand, access, and appreciate the value of their compensation packages. This often leads to underutilization and a disconnect between employer investment and perceived employee value.

"As benefits have multiplied, their value to employees have become fragmented," explained Jaclyn Chen, CEO of Benepass. "By consolidating benefits on a single platform and expanding employee choice, employers can turn benefits into something people actually understand, use, and value. This funding allows us to keep scaling that foundation."

This approach aligns with a broader market shift toward personalization and flexibility. Research shows a vast majority of employees now prioritize personalized benefits that cater to their specific life stages and needs. By moving away from a one-size-fits-all model, companies can significantly boost engagement and position themselves as more attractive employers in a competitive talent market. The platform's success, evidenced by its adoption by over 250 global employers and the processing of more than 4.5 million card transactions, underscores the demand for this modern approach. The company also reports its revenue has more than doubled since January of last year.

A Fintech Answer to an HR Challenge

At its core, Benepass operates as a fintech innovator in the human resources space. The company describes itself as a "global benefits capital management platform," a term that highlights its proprietary financial ledger system. This technology is designed to ensure the precise and compliant distribution of benefit dollars across different programs, currencies, and regulatory environments, a crucial capability for the multinational corporations it targets.

This fintech-centric approach is what attracted lead investor Centana Growth Partners, a firm specializing in the financial services and enterprise technology sectors. The investment validates Benepass's model of applying financial technology principles to solve a pressing HR and finance problem.

Further solidifying its position in the enterprise market is Benepass's status as a Workday Wellness strategic partner. This integration is a powerful differentiator, offering Workday's massive customer base a seamless, pre-vetted solution for financial benefits. For large companies already invested in the Workday ecosystem, this partnership eliminates significant technical hurdles and allows for streamlined data flow between their core HR system and their benefits platform. It signals that Benepass is not just another startup, but a mature, enterprise-ready solution poised to help the world's largest companies navigate the future of employee benefits.